The global covered stent market was valued at USD 1.13 billion in 2023 and is projected to reach USD 1.50 billion by 2030, growing at a CAGR of 4.1% from 2024 to 2030. Growth in this market is being fueled by several key factors, including the increasing prevalence of vascular diseases, ongoing technological advancements in stent design and materials, greater awareness and timely diagnosis of cardiovascular and peripheral vascular conditions, and the expanding use of covered stents across multiple therapeutic applications.

One of the most significant demand drivers is the rising global burden of peripheral artery disease (PAD). According to a report by the American Heart Association (April 2024), PAD currently affects an estimated 116 to 230 million people worldwide, highlighting the urgent need for effective treatment options. Covered stents play a vital role in the management of PAD by providing a reliable solution for revascularization, sealing vascular injuries, and restoring proper blood flow. Their ability to reduce complications such as restenosis, aneurysm rupture, and arterial dissection underscores their importance in modern vascular care.

The market is also benefitting from continuous innovation in stent technology. A study published in February 2023 by MDPI emphasized that covered stents are increasingly being designed with advanced biocompatible polymers, such as polytetrafluoroethylene (PTFE). These polymers act as protective barriers to prevent unwanted tissue ingrowth, thereby minimizing the risk of restenosis (re-narrowing of blood vessels after intervention). Moreover, PTFE and similar coatings have demonstrated effectiveness in sealing off exposed inflammatory surfaces, which can help reduce the development of neointimal hyperplasia (abnormal thickening of the arterial lining). Such advancements significantly enhance patient outcomes and extend the durability of stent implants.

Key Market Trends & Insights:

• Regional Insights: North America dominated the global covered stent market in 2023, accounting for a revenue share of 41.39%. This leadership position can be attributed to high disease prevalence, advanced healthcare infrastructure, widespread adoption of minimally invasive procedures, and the strong presence of leading medical device companies. Meanwhile, the Asia Pacific region is projected to record the fastest growth from 2024 to 2030, driven by rising awareness of vascular diseases, expanding healthcare access, and growing investments in modern medical technologies in countries such as China, India, and Japan.
• By Product: The vascular stent segment held the largest market share of over 64.16% in 2023, as vascular stents are the primary solution for conditions such as PAD, aneurysms, and coronary artery disease. The non-vascular stent segment, which includes stents used in urology, gastroenterology, and other applications, is expected to witness lucrative growth during the forecast period, reflecting broader applications of stent technologies in non-cardiac interventions.
• By End Use: Hospitals represented the largest end-use segment in 2023, accounting for 57.35% of total revenue, owing to the availability of advanced surgical facilities, skilled specialists, and higher patient inflow for complex vascular procedures. However, ambulatory care centers (ACS) are expected to grow at a faster pace during 2024–2030, supported by the rising demand for minimally invasive procedures, shorter recovery times, and cost-effective treatment options outside of traditional hospital settings.

Order a free sample PDF of the Covered Stent Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2023 Market Size: USD 1.13 Billion
• 2030 Projected Market Size: USD 1.50 Billion
• CAGR (2024-2030): 4.1%
• North America: Largest market in 2023
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

The global covered stent market is highly competitive, with major players focusing on expanding their technological capabilities, strengthening product portfolios, and improving global market penetration. Companies are adopting strategies such as M&A, R&D investments, and product launches to stay ahead in the competitive landscape.

Medtronic and Boston Scientific Corporation are two of the leading players, offering a broad range of covered stents designed for both vascular and non-vascular applications.

These companies focus heavily on strategic foresight, including analyzing the strengths and weaknesses of competitors, anticipating future industry trends, identifying growth opportunities, and adapting to challenges arising from emerging technologies, evolving clinical needs, and shifting healthcare policies.

Key Players

• Boston Scientific Corporation
• Medtronic
• W. L. Gore & Associates, Inc.
• Cook
• Terumo Corporation
• B. Braun Interventional Systems, Inc.
• BD
• Getinge
• Biotronik

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global covered stent market is experiencing steady growth, supported by the rising prevalence of vascular diseases like PAD, ongoing innovations in stent materials and design, and the increasing demand for minimally invasive procedures. With North America currently leading and Asia Pacific poised for rapid growth, the market outlook remains strong. Key players such as Medtronic and Boston Scientific are shaping the future of the industry by focusing on innovation, strategic partnerships, and expansion into new healthcare markets.